Skip to main content
. 2017 Jan 20;113(6):598–608. doi: 10.1093/cvr/cvw245

Figure 2.

Figure 2

Kinetics of mouse serum Relaxin-1 and serum levels of Relaxin-2 reached by sRlx injection. (A) Relaxin-1 levels in WT female mice, nulli pari (NP), pregnant (Prg), early (early PP) and late (late PP) postpartum mice (**P < 0.01 vs. NP, n = 5–6), one-way ANOVA, Bonferroni’s Multiple Comparison Test. (B) Serum Relaxin-2 levels in WT-NP mice after daily subcutaneous injection of sRlx-HD and NaCl for 2 days, 6h after the last injection (**P < 0.01 vs. NaCl, n = 3–4 each), unpaired, two-tailed t-test. All data are presented as mean ± SD.